伟思医疗
(688580)
| 流通市值：59.55亿 | | | 总市值：59.55亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 106,040,321.83 | 462,725,664.61 | 325,530,311.85 | 210,453,384.34 |
| 营业收入 | 106,040,321.83 | 462,725,664.61 | 325,530,311.85 | 210,453,384.34 |
| 二、营业总成本 | 74,643,980.57 | 344,480,453.6 | 235,847,318 | 149,767,936.06 |
| 营业成本 | 35,887,302.77 | 156,456,654.82 | 107,877,419.58 | 71,365,174.28 |
| 税金及附加 | 2,485,544.9 | 6,598,119.49 | 4,849,462.71 | 2,973,485.55 |
| 销售费用 | 15,697,981.25 | 91,800,951.92 | 61,113,366.77 | 37,021,094.59 |
| 管理费用 | 10,809,627.29 | 47,361,513.36 | 32,645,201.87 | 19,829,588.28 |
| 研发费用 | 10,780,108.67 | 45,116,123.69 | 31,712,293.48 | 20,483,371.22 |
| 财务费用 | -1,016,584.31 | -2,852,909.68 | -2,350,426.41 | -1,904,777.86 |
| 其中:利息费用 | 4,836.13 | 1,308,051.09 | 1,050,393.12 | 701,883.15 |
| 其中:利息收入 | 1,070,574.96 | 4,212,882.79 | 3,426,329.16 | 2,615,347.78 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 4,835,413.96 | - | - |
| 加:投资收益 | 2,550,983.42 | 12,533,301.1 | 9,763,745.78 | 6,593,169.16 |
| 资产处置收益 | 32,136,104.12 | -880.57 | -864.63 | -864.63 |
| 资产减值损失(新) | - | -430,627.75 | -122,968.26 | - |
| 信用减值损失(新) | 99,626.15 | -835,770.56 | -149,229.7 | -180,911.06 |
| 其他收益 | 4,182,167.54 | 17,976,980.19 | 13,437,510.02 | 9,295,818.99 |
| 四、营业利润 | 70,365,222.49 | 152,323,627.38 | 112,611,187.06 | 76,392,660.74 |
| 加:营业外收入 | 2,213.26 | 2,197,890.44 | 276,467.32 | 155,019.38 |
| 减:营业外支出 | 2,213.94 | 89,857.11 | 13,487.25 | 11,598.68 |
| 五、利润总额 | 70,365,221.81 | 154,431,660.71 | 112,874,167.13 | 76,536,081.44 |
| 减:所得税费用 | 8,791,905.02 | 16,359,015.21 | 10,725,879.9 | 7,211,838.93 |
| 六、净利润 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 | 69,324,242.51 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 | 69,324,242.51 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 | 69,324,242.51 |
| 扣除非经常损益后的净利润 | 33,065,027.7 | 121,384,115.98 | 93,600,044.21 | 63,571,292.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.64 | 1.44 | 1.07 | 0.72 |
| (二)稀释每股收益 | 0.64 | 1.44 | 1.07 | 0.72 |
| 九、综合收益总额 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 | 69,324,242.51 |
| 归属于母公司股东的综合收益总额 | 61,573,316.79 | 138,072,645.5 | 102,148,287.23 | 69,324,242.51 |
| 公告日期 | 2026-04-28 | 2026-04-28 | 2025-10-23 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |